We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Niox Group Plc | NIOX | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.80 | 1.27% | 63.60 | 16:35:29 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 62.60 | 62.60 | 64.00 | 63.60 | 62.80 |
| Industry Sector |
|---|
| BEVERAGES |
| Top Posts |
|---|
Posted at 23/10/2024 10:45 by earwacks Clearly there has been some selling yesterday but quite a few buying back in presumably re-investing winnings. I fully intend to do the same. Just a question of timing. We won’t get another TU update till late January. A lot depends on what mr Griffiths and co do. I think there will be plenty of appetite even if they do offload a few more. Singer have reinstated their buy recommendation even though not increasing revenue upgrade but they have increased the EBITDA ad raised share price target siting further payouts as they accumulate cash again. 5 brokers have targets in a range of 69-91p. The good thing is some kind of dividend or payout is pretty certain plus we don’t yet know how the new upgraded version will sell. They are going to push sales and hoping to grow substantially in the USA. Then there will hopefully be further updates on home test developments. I’m not entirely convinced by Mills suggesting most of the money has been made here. It has more than doubled from its low, but I can see a buyout price in excess of £1.00 per share, although unfortunately probably not Astra (they could buy this with a days revenue possibly). Wallet investor have a 5 year target of £2.67!Maybe many stocks can outstrip that. In the meantime it is definitely a core holding and nice little earner with a 5 percent annual return. GL |
Posted at 16/10/2024 13:07 by earwacks Meeting for tender resolution. 276000 for 3800 against. I can understand the odd 1 or 2 voting against, but nearly 4,000 seems a bit odd. Perhaps it was only 1 or 2 with a lot of voting rights. Would love to know their reasons for not want a premium on a small portion of their shares, especially since 10 million will be held in treasury and the rest cancelled. Looked a no brainer to me and an excellent way of offloading un needed cash pile. It returns value to the company and rewards long term investors handsomely and will reward new investors certainly over the next 2 years. Not saying I would buy anymore right now. See how the dust settles after the payout. |
Posted at 21/7/2024 18:37 by badday Gets a mention on the Paul Scott podcast ( always worth a listen)Interesting that he says Christopher Mills due to do Paul Hills (Vox Markets) interview next week. Christopher Mills was thinking it was fully valued for now, but growing into that value. Might have something to say Anyway Paul Scott comments below: “Another interesting company that I've gone green on, which might surprise you, because it's not my usual sort of value share, is a thing called NIOX, N-I-O-X. That put a trading update out. I had another refresh of the figures. It's quite pricey, but it does something to do with asthma products. And look at the shareholder list on that. You've got Harwood, you've got AstraZeneca, and you've got somebody else who owned about a third of the shares, who were all big name major investors. So the way I look at it is, they've done the due diligence for us, haven't they? And they obviously think it's good, although... Oh, that was it, Rathbones had bought some shares from the other two big shareholders. Richard Griffith, I think, was the other one who's got a big position there. He doesn't get everything right, nobody does, but he's certainly a smart cookie. Anyway, so Niox, I think, is worth you having a look at.” From Small Caps Podcast with Paul Scott: Episode 29 (20 July 2024) - UK Small/Mid Caps with Paul Scott, 20 Jul 2024 This material may be protected by copyright. |
Posted at 27/9/2023 10:05 by thedudie Some extra details from the interim results contained in the report/presentation |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
